183 related articles for article (PubMed ID: 7928234)
1. Effects of superparamagnetic iron oxide (AMI-25) on liver and spleen imaging using spin-echo and fast spin-echo magnetic resonance pulse sequences.
Schwartz LH; Seltzer SE; Adams DF; Tempany CM; Piwnica-Worms DR; Silverman SG; Herman L; Herman LT; Hooshmand R
Invest Radiol; 1994 Jun; 29 Suppl 2():S21-3. PubMed ID: 7928234
[No Abstract] [Full Text] [Related]
2. Detection of focal hepatic lesions: effects of superparamagnetic iron oxide (AMI-25) on magnetic resonance imaging of the liver using T2-weighted fast spin-echo sequences and gradient-and-spin-echo sequences at 1.0 tesla.
Jung G; Krahe T; Kugel H; Gieseke J; Walter C; Lackner K
Invest Radiol; 1998 Feb; 33(2):61-7. PubMed ID: 9493719
[TBL] [Abstract][Full Text] [Related]
3. Superparamagnetic iron oxide hepatic MR imaging: efficacy and safety using conventional and fast spin-echo pulse sequences.
Schwartz LH; Seltzer SE; Tempany CM; Silverman SG; Piwnica-Worms DR; Adams DF; Herman L; Herman LA; Hooshmand R
J Magn Reson Imaging; 1995; 5(5):566-70. PubMed ID: 8574043
[TBL] [Abstract][Full Text] [Related]
4. [Superparamagnetic iron particles. The clinical results in the MR diagnosis of liver metastases].
Ham B; Reichel M; Vogl T; Taupitz M; Wolf KJ
Rofo; 1994 Jan; 160(1):52-8. PubMed ID: 8305693
[TBL] [Abstract][Full Text] [Related]
5. MR imaging of the liver and spleen: a comparison of the effects on signal intensity of two superparamagnetic iron oxide agents.
Chen F; Ward J; Robinson PJ
Magn Reson Imaging; 1999 May; 17(4):549-56. PubMed ID: 10231181
[TBL] [Abstract][Full Text] [Related]
6. The value of fast and ultrafast T2-weighted MR imaging sequences in hepatic enhancement with ferumoxides: comparison with conventional spin-echo sequence.
Abe Y; Yamashita Y; Namimoto T; Tang Y; Takahashi M
Radiat Med; 2000; 18(2):97-105. PubMed ID: 10888042
[TBL] [Abstract][Full Text] [Related]
7. MR enhancement of hepatoma by superparamagnetic iron oxide (SPIO) particles.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Takahashi M
J Comput Assist Tomogr; 1995; 19(4):665-7. PubMed ID: 7622710
[No Abstract] [Full Text] [Related]
8. [Detection of liver lesions: magnetic resonance tomography using superparamagnetic iron particles (AMI-25, endorem) as a contrast medium in comparison with ultrasound diagnosis, computerized tomography and CT portography].
Pleger B; Beyer HK; Laufer U
Rontgenpraxis; 2001; 53(6):245-9. PubMed ID: 11402872
[No Abstract] [Full Text] [Related]
9. Liver MR imaging with iron oxides: toward consensus and clinical practice.
Weissleder R
Radiology; 1994 Dec; 193(3):593-5. PubMed ID: 7972790
[No Abstract] [Full Text] [Related]
10. Superparamagnetic iron oxide: detection of focal liver lesions at high-field-strength MR imaging.
Duda SH; Laniado M; Kopp AF; Grönewäller E; Aicher KP; Pavone P; Jehle E; Claussen CD
J Magn Reson Imaging; 1994; 4(3):309-14. PubMed ID: 8061426
[TBL] [Abstract][Full Text] [Related]
11. Arterioportal shunts in cirrhotic patients: evaluation of the difference between tumorous and nontumorous arterioportal shunts on MR imaging with superparamagnetic iron oxide.
Mori K; Yoshioka H; Itai Y; Okamoto Y; Mori H; Takahashi N; Saida Y
AJR Am J Roentgenol; 2000 Dec; 175(6):1659-64. PubMed ID: 11090400
[TBL] [Abstract][Full Text] [Related]
12. Time-to-echo optimization for spin echo magnetic resonance imaging of liver metastasis using superparamagnetic iron oxide particles.
Alger JR; Harreld JH; Chen S; Mintorovitch J; Lu DS
J Magn Reson Imaging; 2001 Nov; 14(5):586-94. PubMed ID: 11747011
[TBL] [Abstract][Full Text] [Related]
13. Liver metastases: safety and efficacy of detection with superparamagnetic iron oxide in MR imaging.
Bellin MF; Zaim S; Auberton E; Sarfati G; Duron JJ; Khayat D; Grellet J
Radiology; 1994 Dec; 193(3):657-63. PubMed ID: 7972804
[TBL] [Abstract][Full Text] [Related]
14. [Detection of liver lesions with gadolinium-enhanced VIBE sequence in comparison with SPIO-enhanced MRI].
Heim P; Steiner P; Schoder V; Dieckmann C; Kuhlencordt R; Adam G
Rofo; 2003 Oct; 175(10):1376-83. PubMed ID: 14556107
[TBL] [Abstract][Full Text] [Related]
15. Gradient- and spin-echo T2-weighted imaging for SPIO-enhanced detection and characterization of focal liver lesions.
Yoshikawa T; Mitchell DG; Hirota S; Ohno Y; Oda K; Maeda T; Fujii M; Sugimura K
J Magn Reson Imaging; 2006 May; 23(5):712-9. PubMed ID: 16568431
[TBL] [Abstract][Full Text] [Related]
16. Detection and segmental location of malignant hepatic tumors: comparison of ferumoxides-enhanced gradient-echo and T2-weighted spin-echo MR imaging.
Van Beers BE; Lacrosse M; Jamart J; Grandin C; Gigot JF; Horsmans Y; Demeure R; Pringot J
AJR Am J Roentgenol; 1997 Mar; 168(3):713-7. PubMed ID: 9057521
[TBL] [Abstract][Full Text] [Related]
17. Hepatocellular carcinoma in cirrhotic livers: detection with unenhanced and iron oxide-enhanced MR imaging.
Yamamoto H; Yamashita Y; Yoshimatsu S; Baba Y; Hatanaka Y; Murakami R; Nishiharu T; Takahashi M; Higashida Y; Moribe N
Radiology; 1995 Apr; 195(1):106-12. PubMed ID: 7892448
[TBL] [Abstract][Full Text] [Related]
18. Hepatic metastases: diffusion-weighted sensitivity-encoding versus SPIO-enhanced MR imaging.
Nasu K; Kuroki Y; Nawano S; Kuroki S; Tsukamoto T; Yamamoto S; Motoori K; Ueda T
Radiology; 2006 Apr; 239(1):122-30. PubMed ID: 16493012
[TBL] [Abstract][Full Text] [Related]
19. Improved focal liver lesion detection: comparison of single-shot spin-echo echo-planar and superparamagnetic iron oxide (SPIO)-enhanced MRI.
Coenegrachts K; Orlent H; ter Beek L; Haspeslagh M; Bipat S; Stoker J; Rigauts H
J Magn Reson Imaging; 2008 Jan; 27(1):117-24. PubMed ID: 18050350
[TBL] [Abstract][Full Text] [Related]
20. Dextran magnetite as a liver contrast agent.
Magin RL; Bacic G; Niesman MR; Alameda JC; Wright SM; Swartz HM
Magn Reson Med; 1991 Jul; 20(1):1-16. PubMed ID: 1943651
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
